Manuel Constenla

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2006 · 1.9K citations · Full text

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer

Rafael Rosell, G. Robinet, A. Szczęsna et al. · Annals of Oncology · 2007 · 260 citations · Full text

First-line Therapy, Non-small-cell Lung Cancer, Medicine +9

Clinical Benefit With Docetaxel Plus Fluorouracil and Cisplatin Compared With Cisplatin and Fluorouracil in a Phase III Trial of Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group

Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2007 · 250 citations

Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group

Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2007 · 182 citations

A Retrospective Analysis of the Outcome of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Refractory to a Platinum-based Chemotherapy

Xavier León, Ricardo Hitt, Manuel Constenla et al. · Clinical Oncology · 2005 · 178 citations

Medicine, Cancer Recurrence, Cancer Management +11